Skip to main content
University of Maryland 1856

Home

  • Twitter
  • About Us
    • NDEWS Overview
    • People
  • Drugs
    • Drug Information
    • Drug Outbreak Testing Service (DOTS)
    • New Psychoactive Substance (NPS)
    • Toxicology Case Studies - ACMT
    • NDEWS News Scans
    • Social Media Data Mining
  • Project Publications
    • Publications
    • HotSpot Reports
  • Sentinel Sites
    • Sentinel Sites: Reports and Epidemiologists
    • Cross-Site Data Presentation
  • Resources
    • NDEWS Presents Webinars
    • Community Drug Early Warning System (CDEWS)
    • Drug Surveillance Systems in Other Countries
    • National and State Data Sources
    • Supervised Injection Research and Policy
    • Outside Publications
    • Conferences and Meetings
  • Data
  • About Us
    • NDEWS Overview
    • People
  • Drugs
    • Drug Information
    • Drug Outbreak Testing Service (DOTS)
    • New Psychoactive Substance (NPS)
    • Toxicology Case Studies - ACMT
    • NDEWS News Scans
    • Social Media Data Mining
  • Project Publications
    • Publications
    • HotSpot Reports
  • Sentinel Sites
    • Sentinel Sites: Reports and Epidemiologists
    • Cross-Site Data Presentation
  • Resources
    • NDEWS Presents Webinars
    • Community Drug Early Warning System (CDEWS)
    • Drug Surveillance Systems in Other Countries
    • National and State Data Sources
    • Supervised Injection Research and Policy
    • Outside Publications
    • Conferences and Meetings
  • Data
Enter the terms you wish to search for.

Pilot Study Using Electronic Health Records from Hospital Emergency Departments to Monitor Drug Use Trends in Overdose Patients in the Baltimore Area

To see the most current Maryland electronic hospital records (EHR) data, visit the Emergency Department Drug Surveillance (EDDS) system on the CESAR web site. (Posted: June 11, 2020)

 

The University of Maryland Medical System (UMMS) hospitals use the Epic electronic health record (EHR) software to track patient information. This sub-study was designed to use this readily available data to conduct an epidemiologic study of the drugs detected in patients presenting to the emergency department (ED) with a chief complaint and/or diagnosis of overdose or drug-related health problems to better understand patterns in drug use and availability.

The decline in the percentage of specimens testing positive for opiates was not expected. The opiate screen used by the hospitals included in the study primarily detects codeine and the heroin metabolite morphine, but not fentanyl or other synthetic opioids. The decline in opiate positives likely does not reflect patterns of use of synthetic opioids, such as fentanyl.

The Center for Substance Abuse Research (CESAR), which manages the NDEWS Coordinating Center, is participating in the MPowering the State Opioid Use Disorders Project. MPower supports collaborations between research scientists at the University of Maryland’s Baltimore (UMB) and College Park (UMCP) campuses. 

See this 18-page report.

Graph showing percentage of specimens testing positive for specific drugs

Center for Substance Abuse Research
University of Maryland
4321 Hartwick Rd, Ste 501, College Park, MD 20740
Phone: 301-405-9794 ♦ Fax: 301-403-8342
Email: ndews [at] umd.edu ♦ Contact Us ♦ Join Listserv
Disclaimers ♦ Privacy Policy

  • Join the NDEWS Network
  • College Directory
  • Alumni Association
  • UMD Web Accessibility
University of Maryland 1856 - College of Behavioral & Social Sciences

Login / Logout